In liver cancer, ANLN promotes PLK1-mediated phosphorylation of RACGAP1 and subsequent activation of RhoA, thereby ensuring mitotic accuracy, whereas ANLN inhibition disrupts mitosis and effectively suppresses tumor growth (Chen et al., 2022). The gene discussed is ANLN; the disease is neoplasm.